Striatin inhibitors belong to a distinctive chemical class that primarily targets a group of proteins known as striatins. Striatins are large, multi-domain proteins involved in various cellular functions, including signal transduction, cell cycle regulation, and cellular transport processes. The inhibitors designed to modulate striatin activity operate by disrupting the interactions and functions of these proteins within cellular pathways. Understanding the structural intricacies of striatins has paved the way for the development of small molecules capable of selectively inhibiting their activity. The inhibitors work through specific binding sites, hindering the normal functioning of striatins and subsequently influencing the downstream signaling cascades they participate in.
Striatin inhibitors are meticulously designed to interact with the unique domains of striatin proteins, disrupting the intricate networks they form within cells. Researchers have focused on elucidating the precise mechanisms by which these inhibitors interfere with striatin-mediated processes, shedding light on potential applications in various cellular contexts. The development of striatin inhibitors represents a promising avenue for dissecting the intricate web of cellular pathways controlled by these proteins. Unraveling the molecular details of striatin inhibition holds great significance for advancing our understanding of fundamental cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent protein kinase inhibitor that can disrupt striatin signaling by inhibiting kinases that phosphorylate striatin, altering its activity and protein interactions. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
A c-Raf kinase inhibitor that may affect the MAPK/ERK pathway, where striatin can play a role in scaffolding components of this pathway. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can alter chromatin structure and gene expression, potentially affecting striatin's role in the modification of gene expression through its interaction with chromatin-remodeling complexes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can affect the PI3K/Akt pathway, which striatin might be involved in by scaffolding components of this signaling cascade. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that can prevent the activation of the MAPK/ERK pathway, affecting striatin's potential role in this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that may affect striatin signaling through the stress-activated MAPK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can impact striatin by altering the JNK signaling pathway, which might interact with striatin. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor that affects the actin cytoskeleton; since striatin is associated with the cytoskeleton, this inhibitor can influence striatin's role in cytoskeletal organization. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that can disrupt calcium signaling pathways, potentially affecting striatin-mediated calcium-dependent processes. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
A CaMKII inhibitor that, like Calmidazolium, can modulate the activity of striatin through calcium/calmodulin-dependent pathways. | ||||||